BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang JH, Guo W, Liu Z. Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer. World J Gastroenterol 2023; 29(3): 579-581 [PMID: 36688025 DOI: 10.3748/wjg.v29.i3.579]
URL: https://www.wjgnet.com/1007-9327/full/v29/i3/579.htm
Number Citing Articles
1
Masoumeh Mohammadi, Amir Abbas Rafati, Ahmad Bagheri. A Sensitive Electrochemical DNA Biosensor for Determination of Anti-Cancer Drug Gemcitabine Based on an AuNPs/MWCNTs/Carbon Paste ElectrodeJournal of The Electrochemical Society 2023; 170(11): 117510 doi: 10.1149/1945-7111/ad0baa
2
Zhuo Zhong, Jian Yang, Jing-Zi Luo, Xiong Xie, Zhi-Mei Huang, De Long. Efficacy of continuous arterial perfusion chemotherapy combined with transarterial chemoembolization regional arterial thermal perfusion in the treatment of pancreatic cancer with liver metastasesOncology and Translational Medicine 2023;  doi: 10.1097/ot9.0000000000000001
3
Richard Daifuku, Yu Zhang, Jingjing Wang, Qingyang Gu. iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancerTranslational Medicine Communications 2024; 9(1) doi: 10.1186/s41231-024-00161-3